[1] Rossi M,Carioli G,Bonifazi M,et al.Trastuzumab for HER2+ metastatic breast cancer in clinical practice:Cardiotoxicity and overall survival[J].Eur J Cancer,2015,52:41-49.
[2] Schramm A,De Gregorio N,Widschwendter P,et al.Targeted therapies in HER2-positive breast cancer-a systematic review[J].Breast Care (Basel),2015,10(3):173-178.
[3] Ahmed S,Sami A,Xiang J.HER2-directed therapy:Current treatment options for HER2-positive breast cancer[J].Breast Cancer,2015,22(2):101-116.
[4] Shih J,Bashir B,Gustafson KS,et al.Cancer signature investigation:ERBB2 (HER2)-activating mutation and amplification-positive breast carcinoma mimicking lung primary[J].J Natl Compr Canc Netw,2015,13(8):947-952.
[5] Seshie B,Adu-Aryee NA,Dedey F,et al.A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital,Ghana[J].BMC Clin Pathol,2015,15:14.
[6] Ulas A,Kos T,Avci N,et al.Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab:Clinicopathological features,efficacy,and factors affecting survival[J].Asian Pac J Cancer Prev,2015,16(4):1643-1649.
[7] Tsai PW,Shiah SG,Lin MT,et al.Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1.A critical role of p38/nuclear factor-kappa B signaling pathway[J].J Biol Chem,2003,278(8):5750-5759.
[8] Vadlamudi RK,Sahin AA,Adam L,et al.Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215[J].FEBS Lett,2003,543(1-3):76-80.
[9] Wei HY,Ma X.Tamoxifen reduces infiltration of inflammatory cells,apoptosis and inhibits IKK/NF-κB pathway after spinal cord injury in rats[J].Neurol Sci,2014,35(11):1763-1768.
[10] Kim Y,Kang H,Jang SW,et al.Celastrol inhibits breast cancer cell invasion via suppression of NF-κB-mediated matrix metalloproteinase-9 expression[J].Cell Physiol Biochem,2011,28(2):175-184.
[11] Malaponte G,Signorelli SS,Bevelacqua V,et al.Increased levels of NF-κB-dependent markers in cancer-associated deep venous thrombosis[J].PLoS One,2015,10(7):e0132496.
[12] Kamezaki A,Sato F,Aoki K,et al.Visualization of neuregulin 1 ectodomain shedding reveals its local processing in vitro and in vivo[J].Sci Rep,2016,6:28873.
[13] Zhang L,Yi Y,Chen J,et al.Gambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappa B in HeLa cells[J].Biochem Biophys Res Commun,2010,403(3-4):282-287.
[14] Jie H,He Y,Huang X,et al.Necrostatin-1 enhances the resolution of inflammation by specifically inducing neutrophil apoptosis[J].Oncotarget,2016,7(15):1-15.
[15] Pistilli A,Rende M,Crispoltoni L,et al.LY294002 induces in vitro apoptosis and overexpression of p75NTR in human uterine leiomyosarcoma HTB 114 cells[J].Growth Factors,2015,33(5-6):376-383.
[16] Shi X,Xu L,Yu J,et al.Study of inhibition effect of herceptin on interaction between heregulin and erbB receptors HER3/HER2 by single-molecule force spectroscopy[J].Exp Cell Res,2009,315(16):2847-2855.
[17] Cho SJ,Chae MJ,Shin BK,et al.Akt-and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment[J].Mol Med Rep,2008,1(1):83-88.
[18] Hiscox S,Baruha B,Smith C,et al.Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors,heregulin and hyaluronan[J].BMC Cancer,2012,12:458.
[19] Authier H,Billot K,Derudder E,et al.IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors[J].Proc Natl Acad Sci USA,2014,111(41):14794-14799.
[20] Ho YT,Yang JS,Li TC,et al.Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK,IKK,NF-kappa B,u-PA and MMP-2 and-9[J].Cancer Lett,2009,279(2):155-162.